Literature DB >> 1195471

Peyronie's disease: results with dermo-jet injection of dexamethasone.

C C Winter, R Khanna.   

Abstract

The results in 21 patients with Peyronie's disease who were managed with a course of dermo-jet percutaneous injections of dexamethasone into the plaques are described herein. These patients had 6 to 10 injections at intervals of 1 month for 6 months. In a high percentage of the cases there occurred a disappearance or decrease in the size of the plaques, pain on erection and discomfort during sexual relations. Also, there was a high rate of improvement in the chordee. Because of the natural history of resolution of the plaques and the small number of patients, statistical significance is not believed applicable, although 71 per cent of the patients had experienced prior failure with other modes of therapy. Eight patients experienced urinary or prostato-epididymal infections at some time in their medical history, correlating well with the inflammatory theory as the cause of the disorder.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1195471     DOI: 10.1016/s0022-5347(17)67169-6

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  10 in total

Review 1.  Treatment of Peyronie's disease: 2012 update.

Authors:  Ege Can Serefoglu; Wayne J G Hellstrom
Journal:  Curr Urol Rep       Date:  2011-12       Impact factor: 3.092

Review 2.  Update on medical management of Peyronie's disease.

Authors:  Ronny B W Tan; Premsant Sangkum; Gregory C Mitchell; Wayne J G Hellstrom
Journal:  Curr Urol Rep       Date:  2014-06       Impact factor: 3.092

Review 3.  Peyronie's disease.

Authors:  J C Gingell; K M Desai
Journal:  BMJ       Date:  1988-12-10

4.  Peyronie's disease in a district general hospital.

Authors:  V O Odiase; R H Whitaker
Journal:  Postgrad Med J       Date:  1980-11       Impact factor: 2.401

5.  Peyronie's Disease: A Review.

Authors:  Mark Jalkut; Nestor Gonzalez-Cadavid; Jacob Rajfer
Journal:  Rev Urol       Date:  2003

Review 6.  Pharmacological Management of Peyronie's Disease.

Authors:  Landon W Trost; Serap Gur; Wayne J G Hellstrom
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 7.  Conservative management options for Peyronie's disease.

Authors:  Gregory S Jack; Nestor Gonzalez-Cadavid; Jacob Rajfer
Journal:  Curr Urol Rep       Date:  2005-11       Impact factor: 2.862

8.  Current and emerging treatment options for Peyronie's disease.

Authors:  Ahmet Gokce; Julie C Wang; Mary K Powers; Wayne Jg Hellstrom
Journal:  Res Rep Urol       Date:  2013-01-14

9.  Predictors of Pursuing Intralesional Xiaflex in Peyronie's Disease Patients.

Authors:  Nahid Punjani; Bruno Nascimento; Carolyn Salter; Jose Flores; Eduardo Miranda; Jean Terrier; Hisanori Taniguchi; Lawrence Jenkins; John P Mulhall
Journal:  J Sex Med       Date:  2021-07-03       Impact factor: 3.937

Review 10.  Injectable therapy for Peyronie's disease.

Authors:  Weiliang Chong; Ronny Ban Wei Tan
Journal:  Transl Androl Urol       Date:  2016-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.